
Ipca Laboratories (IPCALAB) Share Price rises 2.15% as stock trades at Rs 1,982.10
Updated: 5 Oct 2026 • 10:18 am
Posted by:

Ipca Laboratories Share Price is rising today, with the stock last traded at Rs 1,982.10, up 2.15%, and a market capitalisation of Rs 49,227.5 crore. The move places Ipca Laboratories Ltd. back in focus for readers tracking Ipca Laboratories Share Price, Ipca Laboratories Share Price Today and Ipca Laboratories Stock News. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
The latest Univest figures show an intraday range that has already tested both sides of the opening tone, which makes the Ipca Laboratories Share Price update relevant for short-term observers and longer-term fundamental analysis alike. In Univest coverage, the stock is also important because valuation, earnings quality and Healthcare sector context can be read directly from the same screen. Investors watching Ipca Laboratories Share Price Live can use today’s move as a price action reference, while keeping the company’s ratios and sector positioning in view.
Ipca Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,982.1 |
| Previous Close | Rs 1,940.35 |
| Today's Move | Rs 41.75 (+2.15%) |
| Open | Rs 1,999.9 |
| High | Rs 1,999.9 |
| Low | Rs 1,952.3 |
| Market Capitalisation | Rs 49,227.5 crore |
| Market Cap Category | Large Cap |
Ipca Laboratories Ltd. (IPCALAB) rose to Rs 1,982.1 from the previous close of Rs 1,940.35, a move of Rs 41.75 or 2.15%. The stock opened at Rs 1,999.9, reached a high of Rs 1,999.9, recorded a low of Rs 1,952.3.
Ipca Laboratories Share Price rose by Rs 41.75 today, or 2.15%, to Rs 1,982.10. The stock opened at Rs 1,999.9, matched that level as the day high, and moved to a low of Rs 1,952.3 before trading near Rs 1,982.10. This is the core price action story in Ipca Laboratories Share Price Today.
Compared with the previous close of Rs 1,940.35, the stock is trading higher by a clear absolute amount, while the move from the day open shows that early levels were not sustained. Ipca Laboratories Share Price therefore reflects a positive intraday price rise rather than a one-line drift. For readers following Ipca Laboratories Share Price Update, the important point is that the stock has already moved through a meaningful range and is still trading above its previous close as of 05 October 2026 at 9:52:53 AM IST. That keeps Ipca Laboratories Share Price relevant for Stock Market Today and Share Market Today screens, especially among Stocks in News and Market Movers. The next section looks at the fundamental analysis behind the Ipca Laboratories Share Price trend.
Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 49,227.5 crore |
| P/E Ratio | 37.58x |
| P/B Ratio | 5.8x |
| ROE | 15.88% |
| ROCE | 19.41% |
| EPS | Rs 51.63 |
| Book Value Per Share | Rs 334.38 |
| Dividend Yield | 0.31% |
Ipca Laboratories Ltd. (IPCALAB) fundamental metrics show P/E 37.58x, P/B 5.8x, ROE 15.88%, ROCE 19.41%. These figures provide context only and are not a buy or sell signal.
Ipca Laboratories Ltd. has a market capitalisation of Rs 49,227.5 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 37.58x, P/B at 5.8x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 51.63, book value per share of Rs 334.38, dividend yield of 0.31%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.27x, median ROE of 11.48%, median ROCE of 13.17%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 37.58x |
| Benchmark Median P/E | 32.27x |
| Benchmark Average P/E | 48.67x |
| Benchmark P/E Range | 3.58x to 685.2x |
| Company P/B Ratio | 5.8x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 15.88% |
| Benchmark Median ROE | 11.48% |
| Company ROCE | 19.41% |
| Benchmark Median ROCE | 13.17% |
| Company Market Capitalisation | Rs 49,227.5 crore |
| Benchmark Median Market Cap | Rs 714 crore |
Ipca Laboratories Ltd. (IPCALAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 37.58x, which is above the benchmark median of 32.27x, a difference of +16.45%. On its own, the P/E gap is a valuation reference point, not a trading call.
Ipca Laboratories Ltd. (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 11.48%, a difference of +38.33%. Ipca Laboratories Ltd. (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.17%, a difference of +47.38%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,34,279.63 | 35.9 | 5.02 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,737.12 | 84.35 | 13.97 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,81,129.27 | 83.05 | 20.18 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,239.13 | 25.31 | 4.24 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,08,808.05 | 32.28 | 3.1 | 11.83 | 16 |
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 37.58x compared with the displayed peer median of 35.9x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 15.88% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 49,227.5 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Ipca Laboratories
- Ipca Laboratories Share Price is rising today, which keeps the stock in Stock Updates and Stocks Rising Today screens.
- The latest Univest figures show a clear intraday move from the previous close, making the price action easy to track.
- Ipca Laboratories Fundamental Analysis shows P/E, P/B, ROE, ROCE, EPS and book value in one view.
- The Healthcare sector comparison shows Ipca Laboratories Share Price above the industry P/E median but below the industry average.
- Peer comparison places Ipca Laboratories Share Price between lower-multiple and higher-multiple Pharmaceuticals & Drugs names.
About Ipca Laboratories
Ipca Laboratories Ltd. operates in Healthcare within the Pharmaceuticals & Drugs industry. The company’s share price and financial ratios are tracked by investors because the business sits in a sector where earnings quality, pricing and return ratios matter closely. Ipca Laboratories Share Price is therefore not read only as a one-day move; it is also viewed as a reflection of the company’s position in the pharmaceutical market.
Ipca Laboratories Share Price Today matters to investors who follow the company’s market capitalisation, valuation and capital efficiency. With P/E at 37.58, P/B at 5.8, ROE at 15.88%, ROCE at 19.41%, EPS at 51.63 and book value at Rs 334.38, the company presents a compact set of metrics for stock analysis. Dividend yield stands at 0.31%, which adds one more data point for readers comparing Ipca Laboratories Share Price with other Healthcare names on Univest. In broader Company Overview terms, the stock remains part of the Pharmaceuticals & Drugs universe that is often reviewed for both earnings and valuation discipline.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Ipca Laboratories Share Price rising today?
Ans. Ipca Laboratories Share Price is rising today by 2.15% to Rs 1,982.10. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The move is best read through price action and valuation context.
What is Ipca Laboratories Share Price today?
Ans. Ipca Laboratories Share Price is Rs 1,982.10 as of 05 October 2026 at 9:52:53 AM IST. The stock is up Rs 41.75 from the previous close of Rs 1,940.35 and remains in positive territory.
How much did Ipca Laboratories Share Price gain today?
Ans. Ipca Laboratories Share Price gained 2.15% today. In absolute terms, the stock is higher by Rs 41.75 versus the previous close, which keeps the day’s price action easy to measure alongside the current quote of Rs 1,982.10.
What is the market capitalisation of Ipca Laboratories?
Ans. Ipca Laboratories has a market capitalisation of Rs 49,227.5 crore. That places Ipca Laboratories Share Price in a large listed company profile within Healthcare, with valuation and return metrics that can be compared against industry peers.
How does Ipca Laboratories compare with sector benchmarks?
Ans. Ipca Laboratories Share Price trades at a P/E above the sector median of 32.27 and below the sector average of 48.67. Its ROE and ROCE are also above the same-industry medians, which keeps the comparison relevant.
Who are the main peers for Ipca Laboratories Share Price?
Ans. Key peers include Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd. and Cipla Ltd. Their valuation and return ratios provide a useful frame for Ipca Laboratories Share Price analysis.
Should investors track Ipca Laboratories Share Price on Univest?
Ans. Yes, investors tracking Ipca Laboratories Share Price can monitor live price, valuation ratios, 52-week levels and sector context on Univest. That helps keep Ipca Laboratories Stock News and price action together in one view.
Track Ipca Laboratories Share Price on Univest
Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Ipca Laboratories Share Price on Univest for live share price updates, fundamental ratios, 52-week levels and market insights. The same page also helps compare Ipca Laboratories Share Price with sector context, peer ratios and key company metrics in one place. For anyone following Ipca Laboratories Share News, this is a practical way to monitor the stock without losing sight of valuation and return data.
Recent Articles

Sobha Target Price Rs 1,900: Why Emkay Stays Positive Despite an 18% YTD Fall, With 59% Upside, a Rs 1,571 NAV, SOTP Valuation, the Q2 Business Update and the Risks
5 October 2026

Sobha Target Price Rs 1,900: Why Emkay Stays Positive Despite an 18% YTD Fall, With 59% Upside, a Rs 1,571 NAV, SOTP Valuation, the Q2 Business Update and the Risks
5 October 2026

Jio IPO Buzz: Latest After the US, UK and Dubai Roadshows by Akash and Isha Ambani, the Rs 37,000 to 37,800 Crore Issue, Valuation Estimates and the Financials Investors Are Reading
5 October 2026

Jio Platforms IPO Date: Opening on 21 October, Listing on 28 October, the $3.8 Billion Issue Size, Timeline, How to Apply and What Is Still Unconfirmed
5 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Sobha Target Price Rs 1,900: Why Emkay Stays Positive Despite an 18% YTD Fall, With 59% Upside, a Rs 1,571 NAV, SOTP Valuation, the Q2 Business Update and the Risks
Sobha Target Price Rs 1,900: Why Emkay Stays Positive Despite an 18% YTD Fall, With 59% Upside, a Rs 1,571 NAV, SOTP Valuation, the Q2 Business Update and the Risks
Jio IPO Buzz: Latest After the US, UK and Dubai Roadshows by Akash and Isha Ambani, the Rs 37,000 to 37,800 Crore Issue, Valuation Estimates and the Financials Investors Are Reading
Jio Platforms IPO Date: Opening on 21 October, Listing on 28 October, the $3.8 Billion Issue Size, Timeline, How to Apply and What Is Still Unconfirmed
SEBI Closing Auction Rules: Why the Regulator May Partly Reverse Them After Sharp Derivatives Price Swings, What Changes for Expiry-Day Settlement and What Traders Should Watch

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





